25 results for “cardiomyopathy”. Showing 25 of 39,449.
The genetic architecture of pediatric cardiomyopathy.
cardiomyopathy. Using clinical interpretation guidelines and targeting genes implicated in cardiomyopathy
JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53.
cardiomyopathy, but the exact mechanism is not yet clear. PURPOSE
FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System.
cardiomyopathy and investigated its effects on mitochondrial homeostasis and the cardiomyopathy
SIRT1-FOXOs signaling pathway: A potential target for attenuating cardiomyopathy.
Cardiomyopathy constitutes a global health burden. It refers to myocardial
AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation.
cardiomyopathy. However, functional properties of subcellular AGO2 (Argonaute2), a core
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
cardiomyopathy,” which develops independent of hypertension, coronary heart disease, and other
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
cardiomyopathy is an autosomal-dominant disorder in which 10 genes
Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia.
cardiomyopathy. There were pleomorphic nuclei and focal fibrosis and degeneration
Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis.
cardiomyopathy is a severe cardiovascular disease with a poor prognosis
microRNA-130b-3p Attenuates Septic Cardiomyopathy by Regulating the AMPK/mTOR Signaling Pathways and Directly Targeting ACSL4 against Ferroptosis.
cardiomyopathy. Although the role of miR-130b-3p as an oncogene
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.
cardiomyopathies, including arrhythmogenic cardiomyopathy (ACM), a genetic heart disease plagued
Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.
cardiomyopathy is characterized by structural, valvular, vascular and conduction abnormalities
The restrictive cardiomyopathies.
cardiomyopathies have taken their place as the third major category
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients.
cardiomyopathy. As ATTR cardiomyopathy is associated with a high risk
Marked variation in the cardiomyopathy associated with Friedreich's ataxia.
cardiomyopathy associated with Friedreich's ataxia may offer a human
Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy.
cardiomyopathy (DCM). DCM related to mutations in LMNA is a common
Variant panorama in 1,385 index patients and sensitivity of expanded next-generation sequencing panels in arrhythmogenic disorders.
cardiomyopathy (HCM), dilatative cardiomyopathy (DCM) or arrhythmogenic right ventricular cardiomyopathy
Identification of key genes of diabetic cardiomyopathy in hiPSCs-CMs based on bioinformatics analysis.
cardiomyopathy (DbCM) is one of the most common vascular complications
Cardiomyopathy in Friedreich's ataxia.
cardiomyopathy. Here we explore some of the putative mechanisms underlying
N6-Methyladenosine-mediated phase separation suppresses NOTCH1 expression and promotes mitochondrial fission in diabetic cardiac fibrosis.
cardiomyopathy. However, the molecular mechanism by which m6A-mediated phase
Danon Disease: Entire LAMP2 Gene Deletion with Unusual Clinical Presentation-Case Report and Review of the Literature.
cardiomyopathy, skeletal myopathy, and intellectual disability. It is caused by defects
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.
cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by progressive myocardial
The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin-induced cardiomyopathy.
cardiomyopathy and the underlying mechanisms. EXPERIMENTAL APPROACH: Sixty-five mice
Melatonin attenuates diabetic cardiomyopathy by increasing autophagy of cardiomyocytes via regulation of VEGF-B/GRP78/PERK signaling pathway.
cardiomyopathy (DCM) is a major cause of mortality in patients
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.
cardiomyopathy, diabetic cardiomyopathy and cardiac aging) and the relationship between